Bonnie Berry, Ph.D.

Bonnie Berry, Ph.D. has a diverse work experience spanning a range of scientific fields. Bonnie is currently the Director of Stem Cell and Tissue Engineering at Curi Bio, where they have been since 2019. In this role, their responsibilities are not specified with the provided data.

Prior to their current position, Berry worked as a Senior Research Scientist at Curi Bio from January 2019 to November 2020, and as a Postdoctoral Fellow at the University of Washington from June 2017 to February 2019. At the University of Washington, they focused on investigating the role of Histone Deacetylase 2 (HDAC2) in human induced pluripotent stem cell-derived neurons, specifically in relation to Alzheimer's disease.

Before their tenure at the University of Washington, Berry served as Program Manager at the Institute of Translational Health Sciences from October 2015 to May 2017. In this role, they were responsible for the development and oversight of a Pilot Award Program supporting academic researchers and research clinicians working on translational science. Additionally, they contributed to the organization and management of a $60 million federal grant for the institute's mission. Bonnie also provided assistance and consultation for research activities in the ITHS Gene and Cell Therapy Lab.

From 2009 to 2015, Berry worked at the University of Central Florida as a NanoScience Technology Center Doctoral Research Fellow. During this time, they focused on developing controlled human in vitro systems for high-throughput drug screening and body-on-a-chip systems, with a particular emphasis on creating a bio-mimetic model of Alzheimer's Disease. Bonnie also contributed to industry-backed collaborations and assisted in cooperative lab projects.

Berry's earliest recorded work experience is from 2005 to 2008, when they served as a NASA Florida Space Grant Consortium Masters Research Fellow. Their research involved studying the growth and survival of common biological spacecraft contaminants in harsh environments, specifically at the Kennedy Space Center's Space Life Sciences lab. Bonnie also interned with Dynamac International, Inc. during this time.

Overall, Bonnie Berry, Ph.D. has extensive experience in stem cell and tissue engineering, translational science, neurodegenerative diseases, and space research.

Bonnie Berry, Ph.D. obtained their Doctor of Philosophy (PhD) degree in Biomedical Sciences from the University of Central Florida, studying from 2009 to 2015. Prior to that, they pursued a Master of Science degree in Biology at the same institution, completing their studies from 2005 to 2008. Their educational journey started with a Bachelor of Science degree in Biology, which they earned from the University of Central Florida from 2000 to 2005.